We found that AMH, but not inhibin B, predicted long-term (4–5 year) ovarian function in women with early breast cancer,27 and others found that both AMH and inhibin B were lower in women with chemotherapy-associated amenorrhoea (CRA) at 1 year after chemotherapy for early breast cancer.26 The gene discussed is AMH; the disease is breast carcinoma.